Evidence map›Paper›PMID 33187294›Full record

ArticleMaterials (Basel, Switzerland)2020

A Low-Cost Open Source Device for Cell Microencapsulation.

Miriam Salles Pereira, Liana Monteiro da Fonseca Cardoso, Tatiane Barreto da Silva, Ayla Josma Teixeira, Saul Eliahú Mizrahi, Gabriel Schonwandt Mendes Ferreira, Fabio Moyses Lins Dantas, Vinicius Cotta-de-Almeida, Luiz Anastacio Alves

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 76% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Miriam Salles PereiraLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Liana Monteiro da Fonseca CardosoLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.ORCID 0000-0002-8567-3276
Tatiane Barreto da SilvaLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Ayla Josma TeixeiraLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Saul Eliahú MizrahiNational Institute of Technology-INT, Rio de Janeiro Av. Venezuela, 82-Saúde, Rio de Janeiro 20081-312, Brazil.
Gabriel Schonwandt Mendes FerreiraNational Institute of Technology-INT, Rio de Janeiro Av. Venezuela, 82-Saúde, Rio de Janeiro 20081-312, Brazil.
Fabio Moyses Lins DantasNational Institute of Technology-INT, Rio de Janeiro Av. Venezuela, 82-Saúde, Rio de Janeiro 20081-312, Brazil.ORCID 0000-0002-2233-818X
Vinicius Cotta-de-AlmeidaLaboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Luiz Anastacio AlvesLaboratory of Cellular Communication, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Manguinhos, Rio de Janeiro 21045-900, Brazil.
Fundação Oswaldo Cruz · BRInstituto Nacional de Tecnologia · BRCentro Universitário de Volta Redonda · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microencapsulation is a widely studied cell therapy and tissue bioengineering technique, since it is capable of creating an immune-privileged site, protecting encapsulated cells from the host immune system. Several polymers have been tested, but sodium alginate is in widespread use for cell encapsulation applications, due to its low toxicity and easy manipulation. Different cell encapsulation methods have been described in the literature using pressure differences or electrostatic changes with high cost commercial devices (about 30,000 US dollars). Herein, a low-cost device (about 100 US dollars) that can be created by commercial syringes or 3D printer devices has been developed. The capsules, whose diameter is around 500 µm and can decrease or increase according to the pressure applied to the system, is able to maintain cells viable and functional. The hydrogel porosity of the capsule indicates that the immune system is not capable of destroying host cells, demonstrating that new studies can be developed for cell therapy at low cost with microencapsulation production. This device may aid pre-clinical and clinical projects in low- and middle-income countries and is lined up with open source equipment devices.

Indexed as

3D printeralginatecell therapycell transplantationmicroencapsulation

Identifiers

PMID33187294
PMCPMC7696579
OpenAlexW3098985287

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.